New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal.

This way, SOLACI continues to contribute to advancing research on transcatheter intervention and treating peripheral artery disease across Latin America.  🌎

To be part of the SOLACI PERIPHERAL Registry or learn more about it, contact research@solaci.org

It should be noted that SOLACI Peripheral is a research program open to all centers in Latin America that may be willing to actively participate; in this sense, each participant center will have access to registry data in real time. Furthermore, participants will have authorship rights in all Registry publications and will secure the possibility of using Registry data for their own research projects. 

The benefits of participating

  1. Access our own database dedicated to lower limb angioplasty, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present SOLACI Peripheral outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

Your participation is really important to SOLACI and to the entire SOLACI Peripheral Committee. We would be pleased and honored to have you join us in this important initiative.

To take part of SOLACI Peripheral Registry, please email us to: research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....